Ritch, Elie J.
Herberts, Cameron
Warner, Evan W.
Ng, Sarah W. S.
Kwan, Edmond M.
Bacon, Jack V. W.
Bernales, Cecily Q.
Schönlau, Elena
Fonseca, Nicolette M.
Giri, Veda N.
Maurice-Dror, Corinne
Vandekerkhove, Gillian
Jones, Steven J. M. http://orcid.org/0000-0003-3394-2208
Chi, Kim N.
Wyatt, Alexander W. http://orcid.org/0000-0003-2399-0329
Funding for this research was provided by:
Prostate Cancer Foundation
Article History
Received: 12 November 2022
Accepted: 27 February 2023
First Online: 13 March 2023
Competing interests
: C.M.D. received honoraria from MSD, Bristol-Myers Squibb, Medison and Pfizer and received consulting fees from Biomica. K.N.C. has research funding from Janssen, Astellas and Sanofi. K.N.C. also reports research funding and personal fees from Janssen, Astellas, AstraZeneca and Sanofi, as well as personal fees from Constellation Pharmaceuticals, Daiichi Sankyo, Merck, Novartis, Pfizer, Point Biopharma and Roche outside the submitted work. A.W.W. has served on advisory boards and/or received honoraria from AstraZeneca, Astellas, Bayer, EMD Serono, Janssen, Merck, and Pfizer. The laboratory of A.W.W. has a contract research agreement with ESSA Pharma. The remaining authors declare no competing interests.